Bausch + Lomb Retisert (fluocinolone acetonide intravitreal implant) 0.59 mg is the world's first intravitreal drug implant for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. Uveitis is an inflammation of the uvea (or uveal layer) – the middle layer of three that make up the eye. It is a treatable condition; however, without proper treatment, it can lead to much more serious conditions such as glaucoma, cataracts, or retinal edema.